Associated Papers
Therapeutic inhibition of isocitrate dehydrogenase mutations in glioma and cholangiocarcinoma: new insights and promises-a narrative review.
Internò V et al.
Chinese Clinical Oncology, 2024
The implications of IDH mutations for cancer development and therapy.
Pirozzi CJ et al.
Nature Reviews. Clinical Oncology, 2021
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.
Choe S et al.
Blood Advances, 2020
Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.
Akiyama M et al.
International Journal of Hematology, 2015
Select a paper to view details